ImmunityBio Shares Face Unrelenting Downward Spiral
Published on 11/04/2025 at 17:34 | Redaktion boerse-global.de
The biotechnology sector is demonstrating its notoriously unforgiving nature, with ImmunityBio caught in a severe downturn. As the company’s stock continues to face intense selling activity, investors are questioning whether the bottom has been reached or if further declines are imminent.
Technical analysis presents a concerning outlook for ImmunityBio. Both short-term and long-term moving averages are generating clear sell signals. Since a reversal point in mid-September, the equity has already surrendered more than 20 percent of its value, with technical indicators suggesting additional losses until a new support level is established.
The current technical picture shows four negative signals against zero positive ones—a decisive message. Resistance levels at Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
